Qube Research & Technologies (QRT)
NEXI

Qube Research & Technologies (QRT)’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– -$1 – 4849
2023
Q3 		– Hold
0
– – – 4050
2022
Q4 		– Sell
-562
Closed -$8K – 3113
2022
Q3 		$8K Sell
562
-72
-11% -$2.11K ﹤0.01% 2378
2022
Q2 		$26K Buy
+634
New +$39.3K ﹤0.01% 2237

Other funds holding NEXI

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NEXI Position: Q4 2023 in Review

Qube Research & Technologies (QRT) held its NexImmune, Inc. Common Stock (NEXI) position steady in Q4 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4849.

Qube Research & Technologies (QRT) first reported a position in NEXI in Q2 2022 and has held it in 2 quarters since. The position peaked at $26K in Q2 2022. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

  • Qube Research & Technologies (QRT) held 0 shares of NexImmune, Inc. Common Stock worth $0 as of Q4 2023.
  • Qube Research & Technologies (QRT) left its NexImmune, Inc. Common Stock share count unchanged in Q4 2023.
  • NexImmune, Inc. Common Stock made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q4 2023, its #4849 holding.
  • Qube Research & Technologies (QRT) first reported a position in NexImmune, Inc. Common Stock in Q2 2022 and has held it in 2 quarters since.
  • Qube Research & Technologies (QRT)'s NexImmune, Inc. Common Stock position peaked at $26K in Q2 2022.
  • 11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.